Chapter 22 Flashcards
1
Q
Acromegaly
A
- is a rare condition characterized by an overproduction of growth hormone (GH)
- most often occurs because of a benign growth hormone-secreting pituitary adenoma
- results in an overgrowth of soft tissues and bones in the hands, feet, and face
- prognosis depends of age at onset, age when treatment started, and tumor size
2
Q
ACTH deficiency
A
- with associated loss of cortisol, is a potentially life-threatening disorder
- generalized pituitary hypofunction
3
Q
Advanced glycation end product (AGE)
A
- with recurrent or persistent hyperglycemia, glucose becomes irreversibly bound to collagen and other proteins in RBCs, blood vessel walls, interstitial tissue, and within cells. The products of this binding are known as AGE
4
Q
Autoimmune thyroiditis (Hashimoto disease, chronic lymphocytic thyroiditis)
A
- is caused by the destruction of thyroid tissue by antibodies
- it is the most common cause of hypothyroid goiters in the US
- As thyroid tissue is destroyed by antibodies, there may be a transient phase of hyperthyroidism due to leaking thyroid hormone from the damaged tissues
5
Q
Central (secondary) hyperthyroidism
A
- is less common than primary and is caused by TSH-secreting pituitary adenomas
6
Q
Congenital hypothyroidism
A
- is caused by thyroid hormone deficiencies during fetal or early neonatal life
- AKA cretinism
-All infants are screened for decreased thyroid function at birth - Treatment is synthroid
7
Q
Cushing disease
A
- refers to excess endogenous secretion of ACTH
8
Q
Cushing-like syndrome
A
- may develop as a side effect of long-term pharmacologic administration of glucocorticoids
9
Q
Cushing syndrome
A
- refers to the clinical manifestations resulting from chronic exposure to excess endogenous cortisol
- more common in women
10
Q
Dawn phenomenon
A
- is an early morning rise in blood glucose concentration caused by nocturnal elevations of GH, which decreases metabolism of glucose by muscle and fat
- increasing the dose of evening insulin manages the problem
11
Q
Diabetes insipidus
A
- is an insufficiency of ADH, leadign to polyuria and polydipsia
12
Q
Exopthalmos
A
- protrusion of the eyeball
- present in hypothyroid diseases such as Graves disease
13
Q
Familial hypocalciuric hypercalcemia (FHH)
A
- is a benign autosomal dominant condition that can mimic hyperparathyroidism and is characterized by a high serum calcium level, low serum phosphate level, and low urine calcium excretion
- caused by the mutation in the calcium-sensing receptor in the parathyroid gland
- differentiated from primary hyperparathyroidism gland by measurement of 24-hr urine calcium excretion, which is very low in FHH
14
Q
Feminization
A
- caused by hypersecretion of estrogens
- the development of female sex characteristics
15
Q
FSH deficiency
A
- the onset of FSH and LH deficiencies in women of reproductive age is associated with amenorrhea and with atrophy in the vagina, uterus, and breasts
- in postpubertal males, the testicles atrophy and facial hair growth is diminished
- both men and women experience a decrease in body hair and libido
16
Q
GH deficiency
A
- occurs in children and adults
- may result from any of the causes of hypopituitarism
- in children, it is manifested as hypopituitary dwarfism
17
Q
Ghrelin
A
- DM
- is a peptide produced in the stomach and pancreatic islets that regulates food intake, energy balance, and hormonal secretion
18
Q
Giantism
A
- in children or adolescents whose epiphyseal plates have not yet closed, the effect of increased GH levels causes excessive skeletal growth, with some individuals becoming 8- or 9-feet tall
19
Q
Glucagon
A
- Glucagon is one of several counterregulatory hormones released in response to cellular deficiency of glucose.
- Glucagon suppresses insulin and stimulates hepatic glucose production (from glycogen), resulting in elevated glucose levels.
20
Q
Glycation
A
- is a normal nonenzymic process that involves the reversible attachment of glucose to proteins, lipids, and nucleic acids
21
Q
Graves disease
A
- hyperthyroid condition
- characterized by diffuse thyroid enlargement and excess thyroid hormone secretion
- the patient develops antibodies to the TSH receptor. These antibodies attach to the receptors and stimulate the thyroid gland to release T3, T4, or both
- the excess release of thyroid hormones leads to the clinical manifestations associated with thyrotoxicosis
22
Q
Hyperaldosteronism
A
- is characterized by excess aldosterone secretion by the adrenal cortex
23
Q
Hypercortisolism
A
- hyperfunction that causes increased secretion of cortisol